Serum eosinophil cationic protein and CD23 in acute RSV bronchiolitis

Medical Science Monitor

Volumn 11, Issue 10, 2005, Pages

  Priftis, Kostas N ^a   Papadopoulou, Athina ^a   Liatsis, Emmanuel ^b   Katsikas, Dimitrios ^a   Nicolaidou, Polyxeni ^c   Kanariou, Maria ^b  

^a PENTELI CHILDREN S HOSPITAL   (Greece)

^b AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Acute bronchiolitis; Atopy; CD23; Eosinophil cationic protein; Respiratory syncytial virus

Indexed keywords

CD23 ANTIGEN; CYTOKINE; EOSINOPHIL CATIONIC PROTEIN; IMMUNOGLOBULIN E; SOLUBLE CD23 ANTIGEN; UNCLASSIFIED DRUG;

ANTIBODY RESPONSE; ARTICLE; ATOPIC DERMATITIS; ATOPY; BRONCHIOLITIS; CONTROLLED STUDY; CYTOKINE RELEASE; DEGRANULATION; EOSINOPHIL; FAMILY HISTORY; FEMALE; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; INFANT; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VIRUS INFECTION; WHEEZING;

BRONCHIOLITIS, VIRAL; EOSINOPHIL CATIONIC PROTEIN; FEMALE; HUMANS; INFANT; MALE; RECEPTORS, IGE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS;

EID: 26944471162     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Azevedo I, de Blic J, Vargaftig BB et al: Increased eosinophil cationic protein levels in bronchoalveolar lavage from wheezy infants. Pediatr Allergy Immunol, 2001: 12: 65-72
2. Garofalo R, Kimpen JLL, Welliver RC, Ogra PL: Eosinophil degranulation in the respiratory tract during naturally-acquired respiratory syncytial virus infection. J Pediatr, 1992; 120: 28-32
3. Marguet C, Dean TP, Basuyau JP, Warner JO: Eosinophil cationic protein and interleukin-8 levels in bronchial lavage fluid from children with asthma and infantile wheeze. Pediatr Allergy Immunol, 2001; 12: 27-33
4. Pifferi M, Ragazzo V, Caramella D, Baldini G: Eosinophil cationic protein in infants with respiratory syncytial virus bronchiolitis: predictive value for subsequent development of persistent wheezing. Pediatr Pulmonol, 2001; 31: 419-24
5. Pala P, Bjarnason R, Sigurbergsson F et al: Enhanced IL-4 responses in children with a history of respiratory syncytial vims bronchiolitis in infancy. Eur Respir J, 2002; 20: 376-82
6. Sigurs N: A cohort of children hospitalised with acute RSV bronchiolitis: impact on later respiratory disease. Paediatr Respir Rev, 2002; 3: 177-83
7. Fox GF, Everard ML, Marsh MJ, Milner AD: Randomised controlled trial of budesonide for the prevention of post-bronchiolitis wheezing. Arch Dis Child, 1999; 80: 343-47
8. Rabatte S, Gagro A, Lokar-Kolbas R et al: Increase in CD23+ B cells in infants with bronchiolitis is accompanied by appearance of IgE and IgG4 antibodies specific for respiratory syncytial virus. J Infect Dis, 1997; 175: 32-37
9. El-Radhi AS, Barry W, Patel S: Association of fever and severe clinical course in bronchiolitis. Arch Dis Child, 1999; 81: 231-34
10. Tang RB, Chen SJ: Serum levels of eosinophil cationic protein and eosi-nophils in asthmatic children during a course of prednisolone therapy. Pediatr Pulmonol, 2001; 31: 121-25
11. Sahid El-Radhi A, Hogg CL, Bungre JK et al: Effect of oral glucocoiticoid treatment on serum inflammatory markers in acute asthma. Arch Dis Child, 2000; 83: 158-62
12. Sigurs N, Bjarnason R, Sigurbergsson F: Eosinophil cationic protein in nasal secretion and in serum and myeloperoxidase in serum in respiratory syncytial virus bronchiolitis: relation to asthma and atopy. Acta Paediatr. 1994; 83: 1151-55
13. Colocho Zelaya EA, Orvell C, Strannegard O: Eosinophil cationic protein in nasopharyngeal secretions and serum of infants infected with respiratory syncytial virus. Pediatr Allergy Immunol, 1994; 5: 100-6
14. Oymar K, Elsayed S, Bjerknes R: Serum eosinophil cationic protein and interleukin-5 in children with bronchial asthma and acute bronchiolitis. Pediatr Allergy Immunol, 1996; 7: 180-86
15. Domachowske JB, Dyer KD, Bonville CA, Rosenberg HF: Recombinant human eosinophil-derived neurotoxin/RNase 2 functions as an effective antiviral agent against respiratory syncytial virus. J Infect Dis, 1998; 177: 1458-64
16. Reijonen TM, Kotaniemi-Syrjanen A, Korhonen K, Korppi M: Predictors of asthma three years after hospital admission for wheezing in infancy. Pediatrics, 2000; 106: 1406-12
17. Villa JR, García G, Rueda S, Nogales A: Serum eosinophil cationic protein may predict clinical course of wheezing in young children. Arch Dis Child. 1998; 78: 448-52
18. Carlsen KH, Halvorsen R, Pettersen M, Carlsen KC: Inflammation markers and symptoin activity in children with bronchial asthma. Influence of atopy and eczema. Pediatr Allergy Immunol, 1997; 8: 112-20
19. Monti G, Peltran A, Coscia A et al: A high neonatal serum eosinophil cationic protein level is a risk factor for atopic symptoms. Acta Paediatr, 2004; 93: 765-09
20. Sung RY, Hui SH, Wong CK et al: A comparison of cytokine responses in respiratory syncytial virus and influenza A infections in infants. Eur J Pediatr, 2001; 160: 117-22
21. Barbato A, Panizzolo C, Gheno M et al: Bronchoalveolar lavage in asthmatic children: evidence of neutrophil activation in mild-to-moderate persistent asthma. Pediatr Allergy Immunol, 2001; 12: 73-77
22. Kwinta P, Tomasik T, Mitkowska Z, Pietrzyk JJ: Evaluation of the activity of eosinophils in the blood of very low birth weight infants. Med Sci Monit, 2004; 10(Suppl. 2): 76-79
23. Legg J, Hussain I, Warner J et al: Type 1 and Type 2 Cytokine Imbalance in Acute Respiratory Syncytial Virus Bronchiolitis. Am J Respir Crit Care Med, 2003; 168: 633-39
24. Welliver RC, Duffy L: The relationship of RSV-specific immunoglobulin E antibody responses in infancy, recurrent wheezing, and pulmonary function at age 7-8 years. Pediatr Pulmonol, 1993; 15: 19-27
25. Alexeyev OA, Linderholm M, Elgh F et al: Increased plasma levels of soluble CD23 in haemorrhagic fever with renal syndrome; relation to virus-specific IgE. Clin Exp Immunol, 1997; 109: 351-55
26. Daschner A, Cuellar C, Alonso-Gomez A et al: Serum CD23 is not altered in gastroallergic anisakiasis. but correlates with the production of specific IgE and the amount of polyclonal stimulation. Allergy. 2001; 56: 1003-7
27. Everard ML, Fox G, Walls AF et al: Tryptase and IgE concentrations in the respiratory tract of infants with acute bronchiolitis. Arch Dis Child. 1995: 72: 64-69
28. Stein RT, Sherrill D, Morgan WJ et al: Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet, 1999; 354(9178): 541-45
29. Chen ZM, Mao JH, Du LZ, Tang YM: Association of cytokine responses with disease severity in infants with respiratory syncytial virus infection. Acta Paediatr, 2002; 91: 914-22
30. Bakoula CG, Kafritsa YJ, Kavadias GD et al: Factors modifying exposure to environmental tobacco smoke in children (Athens, Greece). Cancer Causes Control, 1997; 8: 73-76
31. Murray CS, Woodcock A, Smillie FI et al, NACMAAS Study Group: Tobacco smoke exposure, wheeze, and atopy. Pediatr Pulmonol, 2004: 37: 492-98
32. Fitch PS, Brown V, Schock BC et al: Serum eosinophil cationic protein (ECP): reference values in healthy nonatopic children. Allergy, 1999; 54: 1199-203
33. Lodrup Carlsen KC, Halvorsen R, Carlsen KH: Serum inflammatoiy markers and effects of age and tobacco smoke exposure in young non-asthmatic children. Acta Paediatr, 1998; 87: 559-64